| 注册
首页|期刊导航|医药导报|游离药物浓度监测指导癫(癎)患者联合用药

游离药物浓度监测指导癫(癎)患者联合用药

王锦秋 王民 丰艳梅

医药导报2012,Vol.31Issue(3):370-372,3.
医药导报2012,Vol.31Issue(3):370-372,3.DOI:10.3870/yydb.2012.03.035

游离药物浓度监测指导癫(癎)患者联合用药

Effect of Serum Free-drug Monitoring in Guiding Combining Medication for Epileptic Patients

王锦秋 1王民 2丰艳梅1

作者信息

  • 1. 西安交通大学医学院第二附属医院药剂科,710004
  • 2. 西安交通大学药业集团,710061
  • 折叠

摘要

Abstract

Objective To guide a reasonable medication for epileptic patients. Methods The total of 3 906 cases of epileptic patients administrated with valproic acid( VPA ) and carbamazepine( CBZ ) were followed up in No. 2 hospital of Xi'an Jiaotong University from 2007 to 2010,in which 100 samples were taken out for monitoring the serum free-drug concentration. Results The concentration of VPA and CBZ used in combination or alone decreased( 72. 5% vs 54. 8% ) and increased( 58. 0% vs 84. 3% ),respectively. However,at the higher concentration,the protein biding rate was significantly reduced and the free serum level was increased. Conclusion The dosage should be adjusted according to the serum drug monitoring when VPA and CBZ were used together, and the free serum drug concentration should be under supervision at a high dose.

关键词

抗癫(癎)药物/治疗药物监测/游离药物浓度监测

Key words

Anti-epileptic drug/ Therapeutic drug monitoring/ Serum free-drug concentration monitoring

分类

医药卫生

引用本文复制引用

王锦秋,王民,丰艳梅..游离药物浓度监测指导癫(癎)患者联合用药[J].医药导报,2012,31(3):370-372,3.

基金项目

陕西省科学技术研究发展计划项目[2006k14-G5(3)] (3)

医药导报

OA北大核心CSTPCD

1004-0781

访问量0
|
下载量0
段落导航相关论文